Off-pump coronary artery bypass graft surgery (OPCAB) has been performed for many years and its use is increasing frequently, but it remains an open question whether OPCAB provides similar patency to conventional coronary artery bypass graft (CCABG) surgery with cardiopulmonary bypass. The present study assessed the graft patency in patients that had coronary arterial bypass grafting (CABG) performed on-pump and off-pump. A total of 237 patients with CABG performed by a single surgeon were retrospectively studied, in which 100 patients underwent CCABG and 137 patients underwent OPCAB; the two groups were well matched according to relative factors and no significant differences were found in both groups. Postoperatively, systematic assessment on the graft patency of all the patients was conducted with 64-slice multidetector spiral computed tomography angiography (MSCTA) at one month, 1 year, 2 years, 3 years and 4 years, respectively, to provide 641 grafts for analysis. Patency of left internal mammary artery (LIMA) was higher than that of saphenous vein (SVG) in both groups; no significant difference was seen in LIMA patency and SVG patency in both groups. Results of 64-slice MSCTA indicate that OPCAB provides similar patency to CCABG surgery with CPB.

Download full-text PDF

Source
http://dx.doi.org/10.1510/icvts.2008.195511DOI Listing

Publication Analysis

Top Keywords

graft patency
12
patency
8
conventional coronary
8
coronary arterial
8
arterial bypass
8
bypass grafting
8
64-slice multidetector
8
multidetector spiral
8
spiral computed
8
computed tomography
8

Similar Publications

Purpose: To describe and evaluate the efficacy and safety of lacrimal sac to conjunctiva reconstructive ostomy for proximal lacrimal system reconstruction.

Methods: This retrospective study included 41 patients (32 cancer and 9 trauma; 36 primary and 5 secondary) who underwent lacrimal sac to conjunctiva reconstructive ostomy. The technique involves creating a direct connection between a surgical opening in the lacrimal sac, which maintains its bony attachments to prevent ostomy occlusion, and the medial conjunctiva (medial fornix, bulbar, and palpebral).

View Article and Find Full Text PDF

Introduction: Nicaragua is a Central American country with a high prevalence of patients with chronic kidney disease, particularly among young men. This is largely attributable to Mesoamerican nephropathy, a form of interstitial nephritis that predominantly affects young agricultural workers. While the majority of patients have access to chronic dialysis programs, a very small number have an option of receiving a renal transplant.

View Article and Find Full Text PDF

Chitosan is generally considered to be a procoagulant effect, which may cause adverse phenomena such as blood clotting when used in small-diameter vascular grafts. However, it also shows good biocompatibility and anti-inflammatory properties, which can facilitate vascular reconstruction. Therefore, it is significant to transition the effect of chitosan from coagulation promotion to antiplatelet while still harnessing its bioactivity.

View Article and Find Full Text PDF

Objective: Half of re-interventions after fenestrated and branched endovascular aortic repair (FB-EVAR) are target vessel related. Regarding bridging stent choice, existing data are controversial. This meta-analysis aimed to evaluate the performance of Advanta V12/iCAST as bridging stent in FB-EVAR.

View Article and Find Full Text PDF

Objective: Superior vena cava syndrome (SVC) is a debilitating disease, and surgical reconstruction has been described with some of the best results using spiral great saphenous vein (SGSV) grafts. SGSV grafts can be difficult to construct, and a long segment of saphenous vein is needed. Femoral vein has been an excellent conduit for infected aortic and peripheral reconstructions in our hands, and we sought to review outcomes using this conduit for SVC reconstruction.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!